Health
Synthetic nanobodies show potential for new COVID-19 therapies – The Science Board
Synthetic nanobodies may provide a practical avenue for the development of novel COVID-19 therapies compared to human antibodies, which are bulkier and require…
As there are currently no clinically validated vaccines and limited therapeutic treatments for SARS-CoV-2, developing new therapeutics is a worldwide endeavor, with neutralizing antibodies as a central component. However, traditional antibody production suffers from long development times and costly production.
As an alternative to human antibodies, nanobodies (single-domain antibodies) offer a promising approach, conferring the benefits of small size, increased stability, and superior simplicity…
-
Noosa News21 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
General14 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Business23 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
General19 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse